Gerson Juice Protocol

CHIPSA - Centro Hospitalario Internacional Pacifico, SA is the Mexico Center for Integrative Medicine practicing alternative and complementary medical care. Offering a modern, 6 story hospital housing 70 beds with accompany four-bed intensive-care unit, a full-service surgical ER staff and suite, birthing facilities, state-of-the art anesthesiology, immersion hyperthermia technology, alternative medical research laboratory, x-ray, ultrasound and a 24-hour emergency room. CHIPSA is a community hospital serving the local population’s primary care needs, including birthing and emergencies. CHIPSA provides medical care for several regional corporations. The Gerson Plus Program reserves beds for patients arriving from all over the world, seeking treatment of degenerative diseases with the many integrated therapeutic offerings. CHIPSA hospital is a fully accredited, intensive-care, registered facility.

The CHIPSA Gerson Hospital is the founding medical institution of the Gerson+Therapy developed by Max B. Gerson, MD, founder of Immunonutrition, who is known for his many contributions in chronic and degenerative infectious diseases, as well as the treatment for cancer. CHIPSA is devoted to integrative medicine and is the most experienced hospital practicing complementary and immunonutrition and detoxification therapy on the Pacific Rim.

CHIPSA Hospital, #670, Colonia Jardines del Sol, Playas Tijuana, Mexico C.P. 22700

This site or parts thereof may be linked to for reference only and may not be duplicated in any manner without permission with CHIPSA and the Executive Director of CHIPSA.

C.H.I.P.S.A. All rights reserved. / Marca Registrada: #512642, #512643, #512646 / copyright 2005

Gerson Overview

Dr. Max Gerson (1881-1959) and his therapy, which involves mainly diet, dominate the subject matter on this web site.

Although most of what you'll read here focuses on cancer, which is what Dr. Gerson concentrated on in the last two decades of his life, many other chronic and systemic diseases have been successfully treated with this therapy. Dr. Gerson developed his therapy initially to cure his own migraines, then evolved it for the rest of his life as he treated patients for migraine, lupus, tuberculosis, diabetes, heart disease, arthritis, and finally cancer, among other diseases.

Because cancer, in the view subscribed to here, is just one of many illnesses manifesting the more generic problem of "tissue damage syndrome", most of what you'll read even in the cancer-centered documents here is applicable to other diseases.

Dr. Gerson's therapy works to restore cellular health in the entire body, including especially the immune system, which fights antibiotic-resistant microbes equally as well as it fights nonresistant ones.

Dr. Max Gerson's 1958 book on cancer is represented, and you can read his 1954 paper summarizing his view that Cancer is a problem of metabolism and summarizing his treatment as it was then.

Our article on how the Gerson therapy heals explains how too much sodium and too little potassium connects with disease and water retention, and how restoring the sodium/potassium balance in cells is crucial to healing.

Read about the history of his approach and the story of his cancer practice after he emigrated from Germany to New York City in 1938.

A famous German surgeon, Ferdinand Sauerbruch, did a large clinical trial at his hospital using Gerson's diet to cure lupus. There is also a 1992 paper about Systemic lupus erythematosus (SLE).

There is a retrospective study on outcomes from treatment of melanoma and a further elaboration on that study.

There is a large bibliography with links to the documents on this site as well as a bibliography subset covering only the documents on the site.

Listen to two lectures by Gar Hildenbrand about cancer and its treatment.

CHIPSA with the expertise of Gar Hildenbrand provide a CTEP (US National Cancer Institute-style) protocol for treatment and evaluation of patients according to the standards of the US National Institutes of Health, and following the basic rules of evidence-based medicine.

Gar Hildenbrand is a member of the advisory boards of several journals listed in the PubMed of the US National of Library of Medicine, and subsets of your extant retrospective data will be immediately publishable. In fact, we have a Gerson-Therapy-outcomes best-case review that will require only minimal input to bring into shape, and we feel that this may be a good first step in the literature. As regards our future collaborative research efforts, we believe that a combination of prospective and retrospective outcomes research, naturally grounded in robust methodology, will ensure the publication of your results in the peer-reviewed literature.

I am eager to tell our colleagues about our renewed international collaborative, and equally eager to hear of your continued efforts to gain multilateral support. Toward this end, we were pleased to provide you with examples of our work both in the literature and with the NIH.

Please call as soon as you are back in town so that we can get together to further evolve our plans.

All personal best wishes,

Gar Hildenbrand,
President & Executive Director

Christeene Hildenbrand,
Vice-President & Director

7807 Artesian Road, San Diego CA 92127-2117
858-759-2966 • FAX 858-759-2502

Gerson Research Organization